Results 171 to 180 of about 3,654 (190)

Sofosbuvir/velpatasvir/voxilaprevir

Reactions Weekly, 2021
openaire   +2 more sources

Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study

Clinical Infectious Diseases, 2017
David Wyles, Shyam Kottilil, Oluwatoyin Adeyemi   +2 more
exaly  

Sofosbuvir/velpatasvir and sofosbuvir/velpatasvir/voxilaprevir

Reactions Weekly
openaire   +1 more source

Ribavirin/sofosbuvir/velpatasvir

Reactions Weekly, 2021
openaire   +2 more sources

Pharmacokinetic drug evaluation of velpatasvir plus sofosbuvir for the treatment of hepatitis C virus infection

Expert Opinion on Drug Metabolism and Toxicology, 2017
Antonio Rivero, Antonio Rivero-Juárez
exaly  

Ribavirin/sofosbuvir/velpatasvir

Reactions Weekly, 2023
openaire   +1 more source

In vitro resistance profile of hepatitis C virus NS5A inhibitor velpatasvir in genotypes 1 to 6

Journal of Viral Hepatitis, 2019
Hadas Dvory-Sobol, Rudolf K Beran, Guofeng Cheng   +2 more
exaly  

Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials

Clinical Infectious Diseases, 2016
Jason Grebely, Gregory J Dore, Lingling Han   +2 more
exaly  

Sofosbuvir/velpatasvir/voxilaprevir

Reactions Weekly, 2022
openaire   +1 more source

Rapid bioanalytical LC-MS/MS method for the simultaneous determination of sofosbuvir and velpatasvir in human plasma-application to a pharmacokinetic study in Egyptian volunteers

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2018
Ehab F Elkady, Ahmed A Aboelwafa
exaly